AccessPak for HIV PEP Expanded with Kaletra and Agalsidase beta Intravenous
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Agalsidase beta Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: agalsidase beta
Brand name: Fabrazyme
Synonyms: Agalsidase beta, Agalsidase Beta
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Agenerase
- AccessPak for HIV PEP Expanded with Kaletra-Aggrastat
- AccessPak for HIV PEP Expanded with Kaletra-Aggrenox
- AccessPak for HIV PEP Expanded with Kaletra-AgonEaze
- AccessPak for HIV PEP Expanded with Kaletra-Agriflu
- AccessPak for HIV PEP Expanded with Kaletra-Agriflu injection
- Agalsidase beta Intravenous-AccessPak for HIV PEP Expanded with Viracept
- Agalsidase beta Intravenous-Accolate
- Agalsidase beta Intravenous-Accretropin
- Agalsidase beta Intravenous-Accucaine
- Agalsidase beta Intravenous-AccuHist Drops
- Agalsidase beta Intravenous-AccuHist PDX Drops